| miR-505 acts as tumor suppressor in endometrial cancer by regulating TGF-alpha. | endometrial, |
| miR-505 acts as a tumor suppressor in gastric cancer progression through targeting HMGB1 | gastric, |
| MicroRNA-505-5p functions as a tumor suppressor by targeting cyclin-dependent kinase 5 in cervical cancer. | cervical, |
| miR-505 functions as a tumor suppressor in glioma by targeting insulin like growth factor 1 receptor expression | glioma, |
| Expression of Concern: MicroRNA-505-5p functions as a tumor suppressor by targeting Cyclin-Dependent Kinase 5 in cervical cancer | cervical, |
| miR-505 is a novel tumor suppressive miRNA and inhibits cell proliferation by inducing apoptosis | None |
| Study find that miR505 was significantly increased in lung adenocarcinoma (LA). miR505 functions as an oncogene, promoting lung cancer cell proliferation and inhibiting cancer cell apoptosis via the targeting of TP53AIP1. Finally, it was confirmed that miR505 in plasma extracellular vesicles (EVs) could be delivered to lung cancer cells, inhibiting cell apoptosis and promoting cell proliferation by targeting TP53AIP1. | liver,lung, |